✦ LIBER ✦

Genetic polymorphisms associated with outcome in multiple myeloma patients receiving high-dose melphalan

✍ Scribed by Dumontet, C; Landi, S; Reiman, T; Perry, T; Plesa, A; Bellini, I; Barale, R; Pilarski, L M; Troncy, J; Tavtigian, S; Gemignani, F

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Outpatient high-dose melphalan in multip

✍ Mohamad Kassar; Erin Medoff; Stuart Seropian; Dennis L. Cooper 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 129 KB

161The effect of glutamine on disease pr

✍ J.L. Crook; J.K. Wasalenko; R.C. Myhand 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 277 KB

Oral melphalan pharmacokinetics — relati

✍ Hans Ehrsson; Staffan Eksborg; Anders Österborg; Håkan Mellstedt; Astrid Lindfor 📂 Article 📅 1989 🏛 Springer US 🌐 English ⚖ 273 KB

High-dose intravenous melphalan in a pat

✍ Pecherstorfert, M. ;Zimmer-Roth, I. ;Weidinger, S. ;Irsigler, K. ;Halbmayer, W.M 📂 Article 📅 1994 🏛 Springer-Verlag 🌐 English ⚖ 524 KB

MBL2 polymorphism and risk of severe inf

✍ Mølle, I; Peterslund, N A; Thiel, S; Steffensen, R 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 125 KB

Timing of High Dose Melphalan (HDM) and

✍ A. Mahindra; B. Bolwell; L. Rybicki; R. Sobecks; B. Pohlman; S. Andresen; M. Ear 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 75 KB